Prediction via Similarity: Biomedical Big Data and the Case of Cancer Models

被引:0
作者
Boniolo F. [1 ]
Boniolo G. [2 ]
Valente G. [3 ]
机构
[1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, 02215, MA
[2] Dipartimento di Neuroscienze e Riabilitazione, Università di Ferrara, Ferrara
[3] Dipartimento di Matematica, Politecnico di Milano, Milan
关键词
Biomedical Big Data; Cancer; Distance; Models; Prediction; Similarity;
D O I
10.1007/s13347-023-00608-9
中图分类号
学科分类号
摘要
In recent years, the biomedical field has witnessed the emergence of novel tools and modelling techniques driven by the rise of the so-called Big Data. In this paper, we address the issue of predictability in biomedical Big Data models of cancer patients, with the aim of determining the extent to which computationally driven predictions can be implemented by medical doctors in their clinical practice. We show that for a specific class of approaches, called k-Nearest Neighbour algorithms, the ability to draw predictive inferences relies on a geometrical, or topological, notion of similarity encoded in a well-defined metric, which determines how close the characteristics of distinct patients are on average. We then discuss the conditions under which the relevant models can yield reliable and trustworthy predictive outcomes. © 2023, The Author(s).
引用
收藏
相关论文
共 46 条
[1]  
AlQuraishi L.M., Sorger P.K., Differentiable biology: using deep learning for biophysics-based and data-driven modeling of molecular mechanisms, Nature Methods, 18, 10, pp. 1169-1180, (2021)
[2]  
Basu T., Engel-Wolf S., Menzer O., The ethics of machine learning in medical sciences: Where do we stand today?, Indian Journal of Dermatology, 65, pp. 358-364, (2020)
[3]  
Bekisz S., Geris L., Cancer modeling: From mechanistic to data-driven approaches, and from fundamental insights to clinical applications, Journal of Computational Science, 46, (2020)
[4]  
Benzekry S., Artificial Intelligence and mechanistic modeling for clinical decision making in oncology, Clinical Pharmacology and Therapeutics, 108, pp. 471-486, (2020)
[5]  
Benzekry S., Et al., Classical mathematical models for description and prediction of experimental tumor growth, Plos Computational Biology, 10, 8, (2014)
[6]  
Boniolo F., Et al., Artificial intelligence in early drug discovery enabling precision medicine, Expert Opinion on Drug Discovery, 2, pp. 1-17, (2021)
[7]  
Boniolo G., Patchwork narratives for tumour heterogeneity, Logic, Methodology and Philosophy of Science – Proceedings of the 15Th International Congress, pp. 311-324, (2017)
[8]  
Boniolo G., Campaner R., Carrara M., Patient similarity in the era of precision medicine: A philosophical analysis, Erkentnis, pp. 1-22, (2021)
[9]  
Brown S.A., Patient similarity: Emerging concepts in systems and precision medicine, Frontiers in Physiology, 7, (2016)
[10]  
Chen I.Y., Et al., Ethical machine learning in healthcare, Annual Review of Biomedical Data Science, (2020)